Anit-cancer Rituxan cuts lymphoma recurrence in half: study
Friday, May 21, 2010 - 03:31
in Health & Medicine
Long-term treatment with anti-cancer medication Rituxan, produced by Swiss laboratory Roche, can cut the recurrence of follicular lymphoma in some patients by half, a new study said.